期刊文献+

动态增强MRI定量参数与乳腺癌分子亚型的关系 被引量:26

Correlation of quantitative parameters of dynamic contrast-enhanced MRI with subtypes of breast carcinoma
下载PDF
导出
摘要 目的探讨不同分子亚型乳腺癌动态对比增强MRI(DCE-MRI)定量参数及其与预后因子的关系。方法回顾性分析78例乳腺浸润性癌患者治疗前的MRI,测量定量参数Ktrans、Kep和Ve。测定免疫组化指标ER、PR和HER-2,并对分子亚型进行归类。比较不同分子亚型间及雌激素受体(ER)、孕激素受体(PR)、人类表皮生长因子受体(HER-2)不同表达状态时的DCE-MRI定量参数。结果最终68例入组,其中Luminal A型24例,Luminal B型19例,HER-2+型10例,三阴性乳腺癌(TNBC)15例。Kep值在不同分子亚型间差异有统计学意义(P<0.01)。Luminal A型和TNBC的Ktrans、Kep和Ve值的差异均有统计学意义(P均<0.05)。4个亚型中,TNBC的Ktrans和Kep值最大,Ve值最小。ER-者Kep值高于ER+者;PR-者Kep值亦高于PR+者,PR-者与PR+者Ktrans差异有统计学意义。结论通过Ktrans、Kep和Ve值可鉴别Luminal A型乳腺癌和TNBC;不同分子亚型及不同ER、PR表达状态的乳腺癌的Kep值不同。 Objective To explore the quantitative parameters on dynamic contrast-enhanced MRI(DCE-MRI) in patients with different subtypes of breast carcinoma,and to observe the correlation between the parameters and prognostic factors of breast cancers.Methods Totally 78 patients with pathologically proved infiltrating breast carcinoma who underwent DCE-MRI before treatment and quantitative parameters(Ktrans,Kep and Ve) were measured.Estrogen recepter(ER),progesterone receptor(PR) and human epidermalgrowth factor receptor-2(HER-2) were obtained by immunohistochemistry,and then the subtype of every case was decided.The association between parameters and subtypes,as well as prognostic factors were analyzed.Results Among 68 available cases,24 were Luminal A,19 were Luminal B,10 were HER-2+ and 15 were triple-negative breast cancer(TNBC).Kep was significantly different among the four subtypes(P0.01).Ktrans,Kep and Ve were significantly different between Luminal A and TNBC(all P0.05).Among the four subtypes,TNBC had higher Ktrans and Kep and lower Ve.Kep was higher in tumors with ER-than ER+,and Kep was also higher in tumors with PR-than PR+.Ktrans was significantly different between PR-and PR+.Conclusion The differentiation of Luminal A and TNBC by Ktrans,Kep and Ve is applicable.Kep is associated with subtypes of breast cancers and prognostic factors,including ER and PR.
出处 《中国医学影像技术》 CSCD 北大核心 2013年第7期1126-1130,共5页 Chinese Journal of Medical Imaging Technology
关键词 乳腺肿瘤 磁共振成像 分子分型 Breast neoplasms Magnetic resonance imaging Molecular typing
  • 相关文献

参考文献16

  • 1El Khouli RH, Macura KJ, Kamel IR, et al. 3-T dynamic con-trast-enhanced MRI of the breast: Pharmacokinetic parametersversus conventional kinetic curve analysis. AJR Am J Roentgen-ol, 2011,197(.6):1498-1505.
  • 2Yu Y, Jiang Q, Miao Y, et al. , Quantitative analysis of clinicaldynamic contrast-enhanced MR imaging for evaluating treatmentresponse in human breast cancer. Radiology, 2010,257 (1) : 47-55.
  • 3李睿,陈颖.乳腺浸润性导管癌各分子亚型X线表现及临床特征[J].中国医学影像技术,2011,27(3):565-568. 被引量:12
  • 4徐慧,贾文霄,周梅.三阴性乳腺癌MR征象与病理学表现的相关性分析.中国医学影像技术,2010,26(增刊):31-34.
  • 5Lee SH, Cho N, Kim SJ, et al. Correlation between high resolu-tion dynamic MR features and prognostic factors in breast cancer.Korean J Radiol, 2008,9(1) :10-18.
  • 6Tofts PS, BrixG,Buckley DL, et al. Estimating kinetic parame-ters from dynamic contrast-enhanced T(l)-weighted MRI of a dif-fusable tracer: Standardized quantities and symbols. J Magn Re-son Imaging, 1999,10(3) :223-232.
  • 7Hammond ME, Hayes DF, Dowsett M, et al. American societyof clinical oncology/college of American pathologists guidelinerecommendations for immunohistochemical testing of estrogen andprogesterone receptors in breast cancer (unabridged version).Arch Pathol Lab Med, 2010,134(7) :e48-e72.
  • 8Li SP, Taylor NJ, Makris A, et al. Primary human breast adeno-carcinoma: Imaging and histologic correlates of intrinsic suscepti-bility-weighted MR imaging before and during chemotherapy. Ra-diology, 2010,257(3):643-652.
  • 9Pickles MD, Manton DJ, Lowry M, et al. Prognostic value ofpre-treatment DCE-MRI parameters in predicting disease free andoverall survival for breast cancer patients undergoing neoadjuvantchemotherapy. Eur J Radiol, 2009,71(3) :498-505.
  • 10Linderholm BK, Heilborg H, Johansson U, et al. Significantlyhigher levels of vascular endothelial growth factor (VEGF) andshorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol, 2009, 20( 10) : 1639-1646.

二级参考文献47

  • 1Nielsen TO, Hsu FD, Jensen K, et aI. Immunohistochemical and clinical characterization of the Basal-like subtype of invasive breast cancer. Clin Cancer Res, 2004,10(16):5367-5374.
  • 2Yu K, Lee CH, Tap PH, et al. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression acrogs distinct ethnic populations. Clin Cancer Res, 2004,10 (16) :5508-5517.
  • 3Van De Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomaswith poor clinical outcome. Am J Pathol, 2002,161(6) : 1991-1996.
  • 4Obenauer S, Hermann KP, Grabbe E. Applications and literature review of the BI-RADS classification. Eur Radiol, 2005, 15(5) : 1027-1036.
  • 5Perou CM, Serlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature, 2000,406(17):747-753.
  • 6Calza S, Hall P, Auer G, et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res, 2006,8(4) :R34.
  • 7Carey IrA, Perou CM, Livasy CA, et al. Race, breast cancer Lbtypes, and survival in the Carolina Breast Cancer Study. JAA, 2006,295(21) :2492 2502.
  • 8Luck AA, Evans AJ, James Jj, et al. Breast carcinoma with basal phenotype : mammographic findings. AJR Am J Roentgenol, 2008,191(2):346-351.
  • 9Lamb PM, Perry NM, Vinnicombe SJ, et al. Correlation between ultrasound characteristics, mammographie findings and histological grade in patients with invasive duetal carcinoma of the breast. Clin Radio, 2000,55 (1) : 40-44.
  • 10Paradiso A, Mangia A, Barlentta A, et al. Mammography and morphobiologic characteristics of human breast cancer. Tumori, 1993,79(1) :422.

共引文献19

同被引文献206

引证文献26

二级引证文献203

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部